Blue Ocean Pharma Identifying Open Waters and Providing Creative Solutions in the Continuously Evolving Healthcare Market

News provided by

Jan 25, 2012, 06:01 ET

PHILADELPHIA, Jan. 25, 2012 /PRNewswire/ -- Blue Ocean Pharma LLC launched during CBI's 5th Annual Forum on Oncology Commercialization Strategies, being held in Philadelphia. Blue Ocean is on the forefront of developments in the pharmaceutical and healthcare sectors. The focus is on supporting pharmaceutical, biotechnology, and device development, giving healthcare professionals the opportunity to optimize patient care and improve outcomes. "We are using our expertise to create unique and tailored programs across markets to maximize client potential and are excited to showcase Blue Ocean Pharma and the companies in the Group at this event," said Donna J. Schroeder, PharmD, co-founding partner of Blue Ocean Pharma.

(Logo: http://photos.prnewswire.com/prnh/20120125/NY41522LOGO )

Blue Ocean Pharma was founded to meet the needs of an ever more challenging healthcare sector. Clients are looking for innovative solutions to demands placed on them by external influences and are intrigued by the methods utilized by Blue Ocean Pharma and its operating companies: Percolation Communications LLC, i.e. Strategy LLC, and Powered 4 Significance LLC.

"By applying proven theories and processes from other disciplines to clinical and commercialization challenges, we are able to identify market-moving opportunities in collaboration with our client-partners," said Alden E. Masonis, PhD, co-founding partner of Blue Ocean Pharma.

CBI's Annual Forum is a sound opportunity to launch Blue Ocean Pharma, given its commitment to discovering the best solutions to critical issues. Instead of applying business-as-usual tactics, Blue Ocean Pharma believes resources are better spent challenging the status quo. The company itself is operating under a new business model. The enterprise is one of the first in its industry to use a fully virtual platform to address the efficiencies needed in the industry and the opportunities provided through the ability to unite the most highly talented staff members. "This unique business model has been well received by clients and has led to outstanding growth since we started with Percolation Communications in 2006," continued Dr. Masonis.

Blue Ocean Pharma is also pleased to announce its new live, online, interactive Evidence-Based Medicine Debates (EBM Debates™) series, created by Powered 4 Significance. The first series of debates will cover important and controversial issues in the diagnosis and treatment of Alzheimer's disease. The goal is to bring together researchers, thought leaders, and treating physicians to gain insight into the evidence base and enable informed decision-making. For more information on the EBM Debates, please visit www.ebmdebates.com.

Blue Ocean Pharma LLC
The Blue Ocean Pharma Group of companies consists of Percolation Communications LLC (www.percolationcom.com), i.e. Strategy LLC (www.ie-strategy.com), and Powered 4 Significance LLC (www.powered4significance.com). These three brands offer complementary and unique services that provide synergistic support addressing client needs. To learn more about Blue Ocean Pharma, please visit us at www.blueoceanpharma.com.

Blue Ocean Pharma Contact:
Marco Winkler
+1 917 376 3019
[email protected]

SOURCE Blue Ocean Pharma LLC